miR-564 inhibits hepatocellular carcinoma cell proliferation and invasion by targeting the GRB2-ERK1/2-AKT axisChaojie Liang(Beijing Tongren Hospital), Jixiang Wu(Capital Medical University)OncotargetNovember 18, 201710.18632/oncotarget.22504Cited by 25SaveCiteExport RISWatch citationsRelated Papers<p>The Long Non-Coding RNA SBF2-AS1 Exerts Oncogenic Functions In Gastric Cancer By Targeting The miR-302b-3p/E2F Transcription Factor 3 Axis</p>|OncoTargets and Therapy|2019|13